FluINsure™, an inactivated trivalent influenza vaccine for intranasal administration, is protective in human challenge with A/Panama/2007/99 (H3N2) virus

Autor:	Gregory L. White, Louis Fries, Colin Gelder, Rob Lambkin, John S. Oxford, David S. Burt, George H. Lowell
Rok vydání:	2004
Předmět:	Trivalent influenza vaccine Hemagglutination assay business.industry Influenza vaccine medicine.medical_treatment virus diseases General Medicine Virology Virus Immune system Antigen Immunology Medicine Nasal administration business Adjuvant
Zdroj:	International Congress Series. 1263:661-665
ISSN:	0531-5131
Popis:	FluINsure™ is an intranasal influenza vaccine containing inactivated antigens with the Proteosome™ adjuvant. Preclinical and human data have shown a good safety profile and immune responses in both the systemic compartment and mucosal compartments. We immunized adults with baseline A/Panama/2007/99 serum hemagglutination inhibition (HAI) titers
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e0629523dffd81aa613c7d87db569d27 https://doi.org/10.1016/j.ics.2004.02.024 Zobrazit plný text záznamu Full Text from ScienceDirect